BIOYF
Price:
$8.69
Market Cap:
$136.51M
BioSyent Inc., a specialty pharmaceutical company, sources, acquires or in-licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX 150, an oral hematinic; FeraMAX Powder, a water soluble oral iron supplement, which helps the body form red blood cells; and FeraMAX Pd Therapeutic 150 for the prevention and treatment of iron deficiency anemia. It also offers Cathejell, a product indicated for surface anesthesia and lubrication during various procedures, including cystoscopy, catheterization, endourethral operation, endoscopy, proctoscopy, rectoscopy, and tracheal intubation, as well as used for the symptomatic treatm...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2012-02-22
Stock Exchange
OTC
Ticker
BIOYF
According to BioSyent Inc.’s latest financial reports and current stock price. The company's current ROE is 21.76%. This represents a change of 301.23% compared to the average of 5.42% of the last 4 quarters.
The mean historical ROE of BioSyent Inc. over the last ten years is 20.76%. The current 21.76% ROE has changed 4.82% with respect to the historical average. Over the past ten years (40 quarters), BIOYF's ROE was at its highest in in the September 2015 quarter at 10.49%. The ROE was at its lowest in in the December 2020 quarter at 2.48%.
Average
20.76%
Median
20.29%
Minimum
14.16%
Maximum
30.98%
Discovering the peaks and valleys of BioSyent Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 40.55%
Maximum Annual ROE = 30.98%
Minimum Annual Increase = -19.84%
Minimum Annual ROE = 14.16%
Year | ROE | Change |
---|---|---|
2024 | 20.77% | 11.76% |
2023 | 18.59% | 13.60% |
2022 | 16.36% | -17.81% |
2021 | 19.91% | 40.55% |
2020 | 14.16% | -16.38% |
2019 | 16.94% | -18.04% |
2018 | 20.67% | -11.82% |
2017 | 23.44% | -9.03% |
2016 | 25.76% | -16.84% |
2015 | 30.98% | -19.84% |
The current ROE of BioSyent Inc. (BIOYF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
18.57%
5-year avg
17.96%
10-year avg
20.76%
BioSyent Inc.’s ROE is greater than Canntab Therapeutics Limited (0%), greater than Bionoid Pharma Inc. (-20.07%), less than Genix Pharmaceuticals Corporation (6.75%), less than Cipher Pharmaceuticals Inc. (9.85%), less than CENTR Brands Corp. (28.59%), less than Pacific Health Care Organization, Inc. (8.46%), less than BioSyent Inc. (21.76%), less than Where Food Comes From, Inc. (20.41%), greater than Sanara MedTech Inc. (-29.01%),
Company | ROE | Market cap |
---|---|---|
0% | $147.02K | |
-20.07% | $1.90M | |
6.75% | $1.72M | |
9.85% | $250.08M | |
28.59% | $254.47K | |
8.46% | $10.24M | |
21.76% | $136.51M | |
20.41% | $58.90M | |
-29.01% | $268.77M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioSyent Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioSyent Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is BioSyent Inc.'s ROE?
How is the ROE calculated for BioSyent Inc. (BIOYF)?
What is the highest ROE for BioSyent Inc. (BIOYF)?
What is the 3-year average ROE for BioSyent Inc. (BIOYF)?
What is the 5-year average ROE for BioSyent Inc. (BIOYF)?
How does the current ROE for BioSyent Inc. (BIOYF) compare to its historical average?